Profil
Jari Eerik Koistinaho is the founder of Aranda Pharma Oy, founded in 2015.
Dr. Koistinaho was the founder of Medeia Therapeutics Oy, founded in 2006, and held the title of Director.
Dr. Koistinaho is currently a Faculty Member at Stanford University.
Dr. Koistinaho holds a doctorate from the University of Tampere.
Postes actifs de Jari Eerik Koistinaho
| Sociétés | Poste | Début |
|---|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
Anciens postes connus de Jari Eerik Koistinaho
| Sociétés | Poste | Fin |
|---|---|---|
Aranda Pharma Oy
Aranda Pharma Oy BiotechnologyHealth Technology Discovers and develops novel small molecules to combat prostate cancer and neurodegenerative diseases | Fondateur | - |
Medeia Therapeutics Oy
Medeia Therapeutics Oy Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which discovers and develops new therapeutic approaches for diseases with unmet medical needs | Fondateur | - |
Formation de Jari Eerik Koistinaho
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 4 |
|---|---|
Stanford University
Stanford University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Tampere
University of Tampere Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medeia Therapeutics Oy
Medeia Therapeutics Oy Miscellaneous Commercial ServicesCommercial Services Operates a biotechnology company which discovers and develops new therapeutic approaches for diseases with unmet medical needs | Commercial Services |
Aranda Pharma Oy
Aranda Pharma Oy BiotechnologyHealth Technology Discovers and develops novel small molecules to combat prostate cancer and neurodegenerative diseases | Health Technology |
















